Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Merck Tbk. (MERK) vs Midi Utama Indonesia Tbk. (MIDI) Price & Performance

Merck Tbk.Trade
Midi Utama Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Merck Tbk. vs Midi Utama Indonesia Tbk. — how do they compare? Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume), while Midi Utama Indonesia Tbk. trades at Rp266 (market cap 8.89T, 6.27M 24h volume). The key difference: Midi Utama Indonesia Tbk. is far larger — about 5.1× Merck Tbk.'s market cap, and Midi Utama Indonesia Tbk. is more actively traded (6.27M versus 63K). Which is the better fit depends on your goals.

MERKMIDI
Market Cap
1.76T8.89T
Volume
63K6.27M
Lot
63062.74K
Turnover
243.97M1.67B
Average Price
3,872.46266.81
Value
243.97M1.67B
Indicative Equilibrium Price
3,900266
Indicative Equilibrium Volume
1237

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MERK
View details
MIDI
View details

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK

About Midi Utama Indonesia Tbk.

PT Midi Utama Indonesia (the company) was established under its original name of PT Midimart Utama base on notarial deed No.37 of Mr Frans Elsius, S.H, dated on 28 Jun, 2007. The Company’s articles of association has been amended several times, most recently by notarial deed No. 2 of Kamelina, S.H., dated Mar 3, 2010, concerning among others, increase in capital paid up and public offering.

Read more on MIDI